---
created: 2025-04-13
updated: 2025-04-13T10:53
id: ux&PcC_HlO
specialty: obgyn
specialty_id: 188
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-reproductive::reproductive-pathology
  - source/ak-step1-v11::!flag-these-cards::sketchypathadds
  - "source/ak-step1-v11:": 
  - theme/firstaid::15-repro::04-pathology::25-uterine-conditions
  - "source/ak-step1-v11:": 
  - theme/firstaid::15-repro::04-pathology::25-uterine-conditions::non-neoplastic::endometrial-hyperplasia
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypath::08-repro-&-gu::01-uterine-&-vulvovaginal-disorders::01-abnormal-uterine-bleeding-(aub)-&-endometriosis
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::18000-18999::18654
  - source/ak-step1-v11::^other::^expn::jbadd
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::reproductive::jbadds
  - "source/ak-step2-v11:": 
  - theme/uworld::1000-9999::2000-2999::2418"
type: flashcard
---

# Question
What is a risk factor for endometrial hyperplasia due to increased aromatization of androgens to estrogen?   **Obesity (excess adipose tissue)**

---

# Answer
chro unopposed estrogen exposure (eg, obesity, early menarche, late menopause, and chro anovulation) == endometrial hyperplasia via peripheral aromatization of androgens to estrogens in adipose tissue